Internet Archive Scholar

603 A randomized, placebo-controlled, first in human phase I single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy male volunteers of the immunostimulant 7HP349

Lionel Lewis, William Schary, Siddhartha De, Peter Vanderslice, Ronald Biediger, Yared Hailemichael, Darren Woodside, William Overwijk, Frank Lee, Upendra Marathi
2022 Regular and Young Investigator Award Abstracts   unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (728.4 kB)
https://web.archive.org/web/20221116035449/https://jitc.bmj.com/content/jitc/10/Suppl_2/A631.full.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

doi:10.1136/jitc-2022-sitc2022.0603 fatcat:4nf3npr5vncyhodghbuwz34u7u
Citation

Lionel Lewis, William Schary, Siddhartha De, Peter Vanderslice, Ronald Biediger, Yared Hailemichael, Darren Woodside, William Overwijk, Frank Lee, Upendra Marathi. "603 A randomized, placebo-controlled, first in human phase I single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy male volunteers of the immunostimulant 7HP349." Regular and Young Investigator Award Abstracts (2022)